Emerging Pathogenic Actinomycetes
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 474
Special Issue Editor
Special Issue Information
Dear Colleagues,
The class Actinobacteria encompasses the Gram positive bacteria that are distinguished by the high percentage of guanine and cytosine. Although the taxa within the Actinobacteria have an unrivalled ability to produce bioactive compounds of a therapeutic nature, they were not readily seen as the casual agents of disease, however this is changing. The order Corynebacteriales, is now becoming renowned for containing a number of taxa that are significant causal agents of disease, with Mycobacterium tuberculosis being the most recognised. Out of the nineteen genera in the order, ten genera contain species that are pathogens or opportunistic pathogens of plants, animals and humans. Recent increases in the reported infections caused by the within the class Actinobacteria, can be attributed to the increased numbers of immunocompromised patients as well as improved microbiological awareness. Nevertheless, a number of these pathogens are still often missed or misidentified, as it remains difficult to assign unknown, clinically and environmentaly significant pathogens, to the correct genus, let alone to the right species. This in turn can lead to incorrect chemotherapy.
In this Special Issue, we aim to highlight the importance of emerging pathogenic actinomycetes and their diversity.
We invite authors to send in their manuscripts in the area of interest as highlighted below:
Members within the order Corynebacteriales
Actinomadura
Actinomyces
Gardenerella
Propionibacterium
Streptomyces
Dr. Amanda L. Jones
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Actinomycetes
- Pathogens
- Corynebacteriales
- Actinobacteria
- Clinical
- Environmental
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
